Abstract P3-13-04: Effect of age on tolerability and efficacy of eribulin and capecitabine in patients with metastatic breast cancer treated in study 301
Kaufman, PA, Yelle, L, Cortes, J, Perez, EA, Awada, A, Wanders, J, Olivo, MS, He, Y, Dutcus, CE, Twelves, C
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Abstract S6-6: A Phase III, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes
Kaufman, PA, Awada, A, Twelves, C, Yelle, L, Perez, EA, Wanders, J, Olivo, MS, He, Y, Dutcus, CE
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Abstract P3-13-03: A phase III, open-label, randomized study of eribulin versus capecitabine in patients (pts) with metastatic breast cancer (MBC): Effect of post-progression anti-cancer treatments (PPT) and metastatic progression events on overall survival
Awada, A, Kaufman, PA, Yelle, L, Cortes, J, Wanders, J, O'Shaughnessy, J, Olivo, MS, He, Y, Garzon, F, Dutcus, CE, Binder, TA, Twelves, C, Perez, EA
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article